HealthEquity (HQY) shares plummeted 17.39% in pre-market trading on Wednesday following the release of disappointing fourth-quarter earnings and weak fiscal year 2026 guidance. The health savings account (HSA) administrator's performance fell short of analysts' expectations, triggering a significant sell-off among investors.
The company reported adjusted earnings per share of $0.69 for the fourth quarter, missing the analyst consensus estimate of $0.72. While this represents a 9.52% increase from the same period last year, it wasn't enough to satisfy investor expectations. Revenue for the quarter came in at $311.817 million, surpassing the $306.053 million estimate, but the bottom-line miss overshadowed this achievement.
Adding to investor concerns, HealthEquity's outlook for fiscal year 2026 disappointed Wall Street. The company expects adjusted earnings per share between $3.57 and $3.74, with the midpoint falling below the $3.71 analysts had projected. Similarly, the revenue guidance of $1.28 billion to $1.31 billion also came in slightly below market expectations. Despite reporting growth in key metrics such as HSA accounts and total HSA assets, the weaker-than-anticipated earnings and guidance have spooked investors, leading to the significant pre-market plunge. The company also disclosed that gross profit and margins in the quarter were impacted by approximately $17 million of additional service costs related to cybersecurity and fraud prevention measures.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.